You are here » Home » Company » Natco Pharma Ltd

Natco Pharma Ltd.

BSE: 524816 Sector: Health care
NSE: NATCOPHARM ISIN Code: INE987B01026
BSE 00:00 | 16 Nov 735.05 12.35
(1.71%)
OPEN

721.00

HIGH

742.40

LOW

721.00

NSE 00:00 | 16 Nov 733.50 11.00
(1.52%)
OPEN

728.80

HIGH

742.60

LOW

723.10

OPEN 721.00
PREVIOUS CLOSE 722.70
VOLUME 12842
52-Week high 1061.95
52-Week low 637.40
P/E 15.17
Mkt Cap.(Rs cr) 13,580
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 721.00
CLOSE 722.70
VOLUME 12842
52-Week high 1061.95
52-Week low 637.40
P/E 15.17
Mkt Cap.(Rs cr) 13,580
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Natco Pharma Ltd.

Natco Pharma Ltd

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company's focus is primarily on niche therapeutic areas and complex products. The company sells its products in over 40 countries. FDF products are sold in the United States I...> More

Natco Pharma Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   13,580
EPS - TTM () [*S] 48.45
P/E Ratio (X) [*S] 15.17
Face Value ()   2
Latest Dividend (%)   75.00
Latest Dividend Date 20 Aug 2018
Dividend Yield (%) 1.12
Book Value / Share () [*S] 188.64
P/B Ratio () [*S] 3.90
[*C] Consolidated     [*S] Standalone    

Natco Pharma Ltd - Financial Results

Particulars ( cr) Sep 2018 Sep 2017 % Chg
Net Sales 543.5 426.7 27.37
Other Income 40 5.5 627.27
Total Income 583.5 432.2 35.01
Total Expenses 323 304.8 5.97
Operating Profit 260.5 127.4 104.47
Net Profit 181.6 84.4 115.17
Equity Capital 36.9 34.9 -
> More on Natco Pharma Ltd Financials Results

Natco Pharma Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Glenmark Pharma. 647.60 -2.54 18275.27
Abbott India 7604.90 -0.31 16160.41
Sanofi India 6069.40 -1.16 13977.83
Natco Pharma 735.05 1.71 13580.05
Pfizer 2828.80 1.80 12941.76
Jubilant Life 751.10 -0.09 11965.02
Syngene Intl. 577.20 0.01 11544.00
> More on Natco Pharma Ltd Peer Group

Natco Pharma Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 48.34
Banks/FIs 0.72
FIIs 24.32
Insurance 0.00
Mutual Funds 5.13
Indian Public 17.19
Custodians 0.00
Other 4.05
> More on Natco Pharma Ltd Share Holding Pattern

Natco Pharma Ltd - Research Reports

Date Broker Action Price Report
07/11 Equirus Securities Accumulate 957 PDF IconDetails
> More on Natco Pharma Ltd Research Reports

Natco Pharma Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -2.65% -3.21% 0.85% 0.92%
1 Month -0.74% -0.89% 0.84% 0.92%
3 Month -2.27% -2.45% -5.86% -6.17%
6 Month -6.82% -7.12% 0.20% -0.55%
1 Year -17.83% -18.02% 7.10% 4.58%
3 Year 50.29% 49.34% 37.64% 36.84%

Natco Pharma Ltd - STOCK STRENGTH

Today's Low/High 721.00
742.40
Week Low/High 706.15
768.00
Month Low/High 661.35
801.00
YEAR Low/High 637.40
1062.00
All TIME Low/High 1.60
1080.00